UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

IRS Solutions® announced the launch of its Partner Rewards Program, a new initiative that rewards tax professionals who refer ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a ...

A Unit Linked Insurance Plan (ULIP) is a financial instrument that strategically combines essential life insurance coverage ...

Investing.com -- Estrella Immunopharma Inc (NASDAQ:ESLA) stock surged 21.9% Monday after the clinical-stage biopharmaceutical company announced successful results from the second dose cohort in its ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease-lipoprotein a ...

Investing.com -- Athens International Airport reported third-quarter 2025 revenue of €219 million and EBITDA of €157 million, broadly in line with expectations.

The clinical-stage CRISPR genome-editing company reported a 92% overall response rate and 75% complete response rate or better in a 12-patient cohort treated with the recommended dose for expansion.

The awards ceremony will be held at Shiloh, Andheri West, Mumbai on November 13, 2025.